Cargando…
Idiopathic Thrombocytopenic Purpura: A Rare Syndrome with Alemtuzumab, Review of Monitoring Protocol
Alemtuzumab, a humanized monoclonal antibody that targets surface molecule CD52, causes rapid and complete depletion of circulating T- and B-lymphocytes through antibody-dependent cell-mediated and complement-mediated cytotoxicity. Alemtuzumab has demonstrated superior efficacy compared to subcutane...
Autores principales: | Sarvepalli, Deepika, Rashid, Mamoon Ur, Ullah, Waqas, Zafar, Yousaf, Khan, Muzammil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823085/ https://www.ncbi.nlm.nih.gov/pubmed/31720183 http://dx.doi.org/10.7759/cureus.5715 |
Ejemplares similares
-
Postsurgical Refractory Gastroparesis: Response to Botulinum Toxin Therapy
por: Sarvepalli, Deepika, et al.
Publicado: (2020) -
Splenic injuries secondary to colonoscopy: Rare but serious complication
por: Ullah, Waqas, et al.
Publicado: (2020) -
A Rare Complication of Cardiac Ablation: Atrial-esophageal Fistula Presenting as Odynophagia
por: Khan, Muzammil, et al.
Publicado: (2020) -
Idiopathic thrombocytopenic purpura
por: Kayal, L., et al.
Publicado: (2014) -
Octaploidy in idiopathic thrombocytopenic purpura
por: Makroo, R. N., et al.
Publicado: (2011)